Colgate-Palmolive Company $CL Holdings Boosted by Welch Group LLC

Welch Group LLC increased its position in shares of Colgate-Palmolive Company (NYSE:CL) by 1.1% during the third quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 641,292 shares of the company’s stock after acquiring an additional 7,028 shares during the period. Colgate-Palmolive makes up about 1.9% of Welch Group LLC’s holdings, making the stock its 26th biggest position. Welch Group LLC owned 0.08% of Colgate-Palmolive worth $54,715,000 at the end of the most recent reporting period.

Other institutional investors also recently modified their holdings of the company. Cooper Financial Group increased its position in shares of Colgate-Palmolive by 4.0% during the 2nd quarter. Cooper Financial Group now owns 2,947 shares of the company’s stock valued at $270,000 after purchasing an additional 114 shares during the last quarter. Gould Capital LLC boosted its position in Colgate-Palmolive by 38.7% during the 1st quarter. Gould Capital LLC now owns 412 shares of the company’s stock valued at $35,000 after buying an additional 115 shares during the period. Redhawk Wealth Advisors Inc. grew its holdings in Colgate-Palmolive by 2.8% in the 2nd quarter. Redhawk Wealth Advisors Inc. now owns 4,326 shares of the company’s stock worth $397,000 after acquiring an additional 118 shares during the last quarter. SVB Wealth LLC raised its stake in shares of Colgate-Palmolive by 1.4% during the second quarter. SVB Wealth LLC now owns 8,767 shares of the company’s stock valued at $804,000 after acquiring an additional 119 shares during the last quarter. Finally, Sowell Financial Services LLC increased its holdings in Colgate-Palmolive by 2.1% during the 3rd quarter. Sowell Financial Services LLC now owns 5,737 shares of the company’s stock valued at $490,000 after purchasing an additional 119 shares during the period. 80.41% of the stock is currently owned by institutional investors.

Colgate-Palmolive Stock Performance

Shares of Colgate-Palmolive stock opened at $95.35 on Monday. Colgate-Palmolive Company has a 12 month low of $74.54 and a 12 month high of $99.33. The firm has a market capitalization of $76.01 billion, a P/E ratio of 37.39, a P/E/G ratio of 4.59 and a beta of 0.31. The company has a current ratio of 0.46, a quick ratio of 0.30 and a debt-to-equity ratio of 13.82. The business has a fifty day simple moving average of $89.54 and a two-hundred day simple moving average of $89.65.

Colgate-Palmolive (NYSE:CL) last posted its quarterly earnings data on Friday, October 30th. The company reported $0.97 EPS for the quarter, topping the consensus estimate of $0.93 by $0.04. The business had revenue of $5.37 billion for the quarter, compared to analyst estimates of $5.34 billion. Colgate-Palmolive had a net margin of 9.65% and a return on equity of 607.88%. Colgate-Palmolive’s quarterly revenue was up 4.6% on a year-over-year basis. During the same quarter in the previous year, the firm posted $0.91 earnings per share. On average, equities analysts forecast that Colgate-Palmolive Company will post 3.89 earnings per share for the current fiscal year.

Colgate-Palmolive Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Friday, November 13th. Stockholders of record on Tuesday, October 20th will be issued a dividend of $0.53 per share. This represents a $2.12 annualized dividend and a dividend yield of 2.2%. The ex-dividend date is Tuesday, October 20th. Colgate-Palmolive’s dividend payout ratio (DPR) is presently 84.13%.

Wall Street Analysts Forecast Growth

Several research firms have weighed in on CL. Royal Bank Of Canada reiterated an “outperform” rating and issued a $104.00 price objective on shares of Colgate-Palmolive in a report on Tuesday, September 8th. TD Cowen upped their target price on Colgate-Palmolive from $85.00 to $90.00 and gave the company a “hold” rating in a report on Monday, August 3rd. Barclays raised their price target on Colgate-Palmolive from $80.00 to $87.00 and gave the stock an “equal weight” rating in a research note on Tuesday, July 21st. Citigroup boosted their price objective on shares of Colgate-Palmolive from $105.00 to $110.00 and gave the company a “buy” rating in a research report on Tuesday, July 14th. Finally, Sanford C. Bernstein reaffirmed a “market perform” rating on shares of Colgate-Palmolive in a research report on Thursday, August 13th. Thirteen investment analysts have rated the stock with a Buy rating and seven have given a Hold rating to the company’s stock. According to data from MarketBeat, Colgate-Palmolive has a consensus rating of “Moderate Buy” and an average target price of $99.17.

Insider Transactions at Colgate-Palmolive

In other Colgate-Palmolive news, CEO Noel R. Wallace sold 161,021 shares of Colgate-Palmolive stock in a transaction on Tuesday, August 4th. The stock was sold at an average price of $91.92, for a total transaction of $14,801,050.32. Following the completion of the transaction, the chief executive officer owned 362,231 shares in the company, valued at approximately $33,296,273.52. The trade was a 30.77% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, Director John T. Cahill sold 4,170 shares of the business’s stock in a transaction on Thursday, August 6th. The stock was sold at an average price of $93.37, for a total value of $389,352.90. Following the completion of the sale, the director directly owned 28,373 shares in the company, valued at $2,649,187.01. This trade represents a 12.81% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Insiders have sold a total of 175,191 shares of company stock valued at $16,110,903 in the last ninety days. 0.43% of the stock is currently owned by corporate insiders.

Colgate-Palmolive Company Profile

Colgate-Palmolive Company (NYSE: CL) is a global consumer products company focused on oral care, personal care, home care and pet nutrition. Its portfolio includes toothpaste, toothbrushes, mouthwash, liquid hand soap, body wash, deodorants, household cleaning products and pet food and treats.

The company markets well-known brands such as Colgate, Palmolive, elmex, meridol, Softsoap, Irish Spring, Ajax, Protex and Hill’s Science Diet. Colgate-Palmolive also provides veterinary and nutritional products through Hill’s Pet Nutrition, which serves pet owners and animal health professionals.

Founded in 1806 by William Colgate, the company developed from a soap and candle business into a diversified consumer goods manufacturer.